HIRGOG 150IU
Menotropin (FSH + LH) is used to stimulate ovarian follicular growth and maturation, as well as induce ovulation in women undergoing fertility treatments like anovulation or controlled ovarian hyperstimulation. It may also be used in men to stimulate spermatogenesis in cases of hypogonadotropic hypogonadism.
As Directed by the Physician. Keep out of reach of children.
Store at a temperature not exceeding 20°C. Protected from light.
Menotropin, a gonadotropin, provides both Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH) activity. FSH stimulates ovarian follicle development in women and spermatogenesis in men, while LH is crucial for follicular maturation, ovulation, and corpus luteum formation. This dual action helps address hormonal deficiencies affecting fertility.
- Promotes ovarian follicle development
- Facilitates ovulation in women undergoing fertility treatment
- Supports assisted reproductive technologies (ART)
- Contributes to spermatogenesis in men
* % Daily Value based on 2000 kcal diet. As directed by physician.
Each Combipack contains: Each vial contains: Menotropin IP Equivalent to Follicle stimulating Hormone 150 IU, Luteinizing Hormone 150 IU. Reconstitute with 1 ml Sodium Chloride Injection IP (0.9% w/v) provided with this pack. Each ml contains: Sodium Chloride IP 0.9% w/v, Water for Injections IP q.s.
Related Products
View All →Dyroxenta Tablets
Dydrogesterone is indicated for the treatment of various gynecological conditions caused by progesterone deficiency, including dysmenorrhea, endometriosis, premenstrual syndrome, irregular menstrual cycles, dysfunctional uterine bleeding, secondary amenorrhea, and to prevent threatened or habitual abortion.
Luteofill Injection
Luteofill, containing Progesterone, is indicated for conditions requiring progesterone supplementation. This includes supporting early pregnancy, treating recurrent miscarriages, managing menstrual disorders like amenorrhea or abnormal uterine bleeding, and as part of hormone replacement therapy.
Luteofill Gel
Progesterone gel for vaginal use is typically indicated for luteal phase support in women undergoing Assisted Reproductive Technology (ART) procedures. It helps in preparing the uterine lining for embryo implantation and maintaining early pregnancy, especially in cases of inadequate endogenous progesterone production.
